Data generated from gene and protein expression studies on lymphoma and healthy canine cells revealed an overexpression of this receptor on cNHL cells, confirming the canine CD20 as a promising target for veterinary immunotherapies. The gene discussed is MS4A1; the disease is lymphoma.